Clinical Trial

Accurate Prostate Cancer Following Using Low-Field MRI (Low-PRISM)

Study acronym: Low-PRISM
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 3, 2025 (before its estimated May 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study compares the effectiveness of low-field MRI (0.55T) with high-field MRI (3T) in prostate cancer screening and image quality. It consists of three phases: optimizing the low-field MRI protocol with healthy volunteers, evaluating image quality in patients with metallic artifacts (like hip prostheses), and assessing low-field MRI in patients with suspicious prostate lesions found on high-field MRI.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-06-25; most recent amendment 2025-03-31.
Status change: Not Yet Recruiting → Recruiting 2025-03-31
Trial Details
NCT Number NCT06482489
Lead Sponsor University of Lausanne Hospitals
Conditions Prostate Cancer
Enrollment 74 participants
Start Date 2024-11-01
Primary Completion 2025-05-31 (estimated)
Study Completion 2025-07-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-03